NCT05657756

Brief Summary

One of the common serious complications in the postoperative phase is Residual the neuromuscular blockade that confused the anesthesia medical team also patients may become uncomfortable, un ability to clear secretion, un-explanation of decreasing SPO2, increase respiratory effort and lead to an increase in the risk of respiratory complication. Most clinicians used clinical assessment to evaluate neuromuscular recovery such as a head lift for 5 seconds, Sustain leg lift, Tongue protrusion, teeth clenching, swallowing, Tidal volume 5 mL/kg, Handgrips Sustained for 5 seconds, and other clinical assessments in patients undergoing general anesthesia. A few studies have been discussing the utilization of hand dynamometers in the assessment of post-residual neuromuscular block. Our aim is to examine the neuromuscular recovery using a hand dynamometer after receiving Atracurium versus Rocuronium.

Trial Health

43
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
100

participants targeted

Target at P50-P75 for not_applicable

Timeline
Completed

Started Jun 2023

Shorter than P25 for not_applicable

Geographic Reach
1 country

1 active site

Status
unknown

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

November 4, 2022

Completed
2 months until next milestone

First Posted

Study publicly available on registry

December 20, 2022

Completed
5 months until next milestone

Study Start

First participant enrolled

June 1, 2023

Completed
1 month until next milestone

Primary Completion

Last participant's last visit for primary outcome

July 1, 2023

Completed
1 month until next milestone

Study Completion

Last participant's last visit for all outcomes

August 10, 2023

Completed
Last Updated

December 20, 2022

Status Verified

December 1, 2022

Enrollment Period

1 month

First QC Date

November 4, 2022

Last Update Submit

December 11, 2022

Conditions

Outcome Measures

Primary Outcomes (1)

  • 100 patients were enrolled in our study, they are receiving muscle relaxants either Atracurium or rocuronium, and we recorded the muscle strength of the forearm in a postoperative location using an electronic hand dynamometer with a kilogram scale.

    record the neuromuscular recovery using a hand dynamometer with a kilogram scale

    up to 6 months

Study Arms (2)

Atracrium group

OTHER
Device: Randomize clinical trial using hand dynamometer

Rocoronium group

OTHER
Device: Randomize clinical trial using hand dynamometer

Interventions

Our research article involves 100 patients aged over 18 years old with ASAI\&II divided into two groups, 50 patients will receive atracurium (0.5 mg/kg) and 30 patients receive Rocuronium (0.6 mg/kg). All of our patients will be undergoing elective laparoscopic surgery for cholecystectomy; the patients will randomly select to receive standard anesthesia induction with propofol (2 mg/kg), fentanyl (1-2 mcg/kg), and isoflurane 1.2 Mac, except muscle relaxant. Neuromuscular will monitoring by Train-of-Four (TOF) during surgery.

Atracrium groupRocoronium group

Eligibility Criteria

Age18 Years - 60 Years
Sexall
Healthy VolunteersYes
Age GroupsAdult (18-64)

You may qualify if:

  • all patient between 18-60 years old with ASAII under general anesthesia

You may not qualify if:

  • all patient under 18 years old and over 60 years old
  • prior administration of suxamethonium
  • patient received magnesium, lithium, Quinidine, calcium channel blockers, local anesthesia

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

mohammed abdulzahra Sasaa

Najaf, Adala, 54001, Iraq

RECRUITING

Central Study Contacts

Mohammed abdulzahra sasaa, phd

CONTACT

Ahmed AD sahib, phd

CONTACT

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
DOUBLE
Who Masked
CARE PROVIDER, INVESTIGATOR
Purpose
DIAGNOSTIC
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
principle investigator

Study Record Dates

First Submitted

November 4, 2022

First Posted

December 20, 2022

Study Start

June 1, 2023

Primary Completion

July 1, 2023

Study Completion

August 10, 2023

Last Updated

December 20, 2022

Record last verified: 2022-12

Data Sharing

IPD Sharing
Will not share

Locations